Zobrazeno 1 - 10
of 95
pro vyhledávání: '"J W, MOSLEY"'
Autor:
Leonard B. Seeff, Eva Operskalski, Janel Dockter, Cristina Giachetti, Leslie H. Tobler, Bruce Phelps, W. W. Andrews, J W Mosley, Michael P. Busch, Z. J. Buskell
Publikováno v:
Journal of Viral Hepatitis. 15:120-128
Summary. Knowing the likely distribution of intervals from hepatitis C infection to first RNA-negativity is important in deciding about therapeutic intervention. Prospectively collected sera and data from the Transfusion-transmitted Viruses Study (19
Autor:
S.H. Kleinman, Eva Operskalski, J W Mosley, M. Lee, E.R. Schiff, C.E. Stevens, Hang Lee, Michael P. Busch, Marcia Harris
Publikováno v:
Transfusion. 34:858-864
BACKGROUND: The long-term course of human immunodeficiency virus type 1 (HIV-1)-related disease among seropositive blood donors has not been described. The enrollment and epidemiologic background of HIV-1- infected donors in the Transfusion Safety St
Autor:
Luiz H. Barbosa, F B Hollinger, W. Huang, George J. Nemo, Cladd E. Stevens, D.O. Stram, J W Mosley, R D Aach, Marek Nowicki
Publikováno v:
Transfusion. 36:776-781
Background: Hepatitis virus(es) that are neither hepatitis B (HBV) nor hepatitis C (HCV) (non-B, non-C [NBNC]) may be transmitted by transfusion. The present study assessed donor values for alanine aminotransferase (ALT) and antibody to hepatitis B c
Autor:
J W Mosley
Publikováno v:
Vox Sanguinis. 67:12-15
Hepatitis A virus (HAV) infection occurred after administration of factor VIII concentrate in Europe associated with one manufacturing process. We determined if there was an excess prevalence of anti-HAV among hemophiliacs in the United States, and w
Autor:
C K Kasper, G Gjerset, R B Counts, J W Mosley, Mary Ann Fletcher, Elizabeth Donegan, M C Pike, Yi Zhou, J W Parker, J Hassett
Publikováno v:
Blood. 84:1666-1671
Low- and intermediate-purity clotting-factor therapies are believed to accelerate human immunodeficiency virus (HIV) progression in hemophiliacs through adverse immune effects of the other plasma proteins in the preparations. To investigate this post
Autor:
Louis M. Aledort, Eva Operskalski, Carol K. Kasper, J W Mosley, M. W. Hilgartner, Marek Nowicki, Elizabeth Donegan
Publikováno v:
Vox Sanguinis. 67:24-28
To address the question of HAV prevalence and seroconversion in relation to clotting factor concentrates, we assayed an early serum for 339 hemophiliacs followed every 6 months by the Transfusion Safety Study in the period from mid-1985 until mid-199
Autor:
Joseph Heitman, Michael P. Busch, G F Gjerset, G J Marshall, M Adams, Tzong-Hae Lee, J W Mosley
Publikováno v:
Transfusion. 33:504-508
Storage of lymphocytes for later use in prospective epidemiologic studies of blood donors and transfusion recipients has been limited by the cost of separating peripheral blood mononuclear cells (PBMCs). When the Transfusion Safety Study began in 198
Publikováno v:
Transfusion. 32:68-71
The present criteria for confirmation of human T-lymphotrophic virus types I and II (HTLV-I/II) infection in blood donors are based on seroreactivity to p24 (gag) and gp46 and/or gp61 (env) on Western blot (WB) and radioimmunoprecipitation assays (WB
Autor:
J W, Mosley, E A, Operskalski, L H, Tobler, Z J, Buskell, W W, Andrews, B, Phelps, J, Dockter, C, Giachetti, L B, Seeff, M P, Busch
Publikováno v:
Journal of viral hepatitis. 15(2)
Knowing the likely distribution of intervals from hepatitis C infection to first RNA-negativity is important in deciding about therapeutic intervention. Prospectively collected sera and data from the Transfusion-transmitted Viruses Study (1974-1980)